Over ten-year insulin independence following single allogeneic islet transplant without T-cell depleting antibody induction

被引:8
|
作者
Williams, Jack [1 ]
Jacus, Nicholas [1 ]
Kavalackal, Kevin [1 ]
Danielson, Kirstie K. [1 ,2 ]
Monson, Rebecca S. [1 ]
Wang, Yong [1 ]
Oberholzer, Jose [1 ]
机构
[1] Univ Illinois, Dept Surg, Div Transplant, 840 S Wood St,Rm 428, Chicago, IL 60612 USA
[2] Univ Illinois, Sch Publ Hlth, Div Epidemiol & Biostat, Chicago, IL USA
关键词
autoimmunity; immunosuppression; insulin independence; islet transplantation; T-cell depletion; TYPE-1; OUTCOMES;
D O I
10.1080/19382014.2018.1451281
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Islet cell transplantation is a promising functional cure for type 1 diabetes; however, maintaining long-term islet graft function and insulin independence is difficult to achieve. In this short report we present a patient with situs inversus, who at the time of islet transplantation had a 26-year history of type 1 diabetes, complicated by hypoglycemic unawareness and severe hypoglycemic events. After a single allogeneic islet transplant of a low islet mass, and despite developing de novo anti-insulin and anti-GAD65 autoantibodies, the patient has remarkably maintained insulin independence with tight glycemic control and normal metabolic profiles for 10years, after receiving prolonged non-T-cell depleting immunosuppression.
引用
收藏
页码:168 / 174
页数:7
相关论文
共 9 条
  • [1] Induction immunosuppression with T-cell depleting antibodies facilitates longterm insulin independence after islet allotransplantation in type 1 diabetes
    Bellin, Melena
    Barton, Franca
    Hering, Bernhard
    [J]. XENOTRANSPLANTATION, 2009, 16 (06) : 541 - 541
  • [2] Induction Immunosuppression with T-Cell Depleting Antibodies Facilitates Long-Term Insulin Independence after Islet Allotransplantation in Type I Diabetes
    Hering, Bernard
    Bellin, Melena
    Barton, Franca
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2010, 10 : 141 - 142
  • [3] Early Loss of Transplanted Allogeneic Islets Despite T-Cell Depleting Induction: The Role of Autoimmunity in Clinical Islet Transplantation
    Takita, Morihito
    Shahbazov, Rauf
    Kunnathodi, Faisal
    Mueller, Cynthia
    Kurup, Parvathi
    Kanak, Mazhar
    Lawrence, Michael
    Onaca, Nicholas
    Ueno, Hideki
    Naziruddin, Bashoo
    Levy, Marlon
    [J]. TRANSPLANTATION, 2013, 96 (06) : S121 - S121
  • [4] PHENOTYPES OF ACUTE CELLULAR REJECTION OF LUNG TRANSPLANT RECIPIENTS FOLLOWING INDUCTION THERAPY WITH T-CELL DEPLETING AGENTS
    Spichty, Kathy
    Girnita, Alin
    Zaldonis, Diana
    Pilewski, Joseph
    McCurry, Kenneth
    Zeevi, Adriana
    [J]. HUMAN IMMUNOLOGY, 2008, 69 : S25 - S25
  • [5] Phenotypes of acute cellular rejection of lung transplant recipients following induction therapy with T-Cell depleting agents
    Zeevi, Adriana
    Spichty, Kathy
    Girnita, Alin
    Zaldonis, Diana
    Pilewski, Joseph
    Toyoda, Yoshiya
    McCurry, Kenneth
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2008, 8 : 262 - 262
  • [6] Deceased Donor HLA Antibody Incompatible Renal Transplantation without Antibody Removal: High Incidence of Acute Rejection Reduced by T-Cell Depleting Induction Therapy
    Jolly, E. C.
    Taylor, C. J.
    Key, T.
    Morgan, H.
    Peacock, S.
    Clatworthy, M. R.
    Torpey, N.
    [J]. TRANSPLANTATION, 2012, 94 (10) : 1076 - 1076
  • [7] Deceased Donor HLA Antibody Incompatible Renal Transplantation Without Antibody Removal: High Incidence of Acute Rejection Reduced By T-Cell Depleting Induction Therapy
    Jolly, E.
    Taylor, C.
    Morgan, H.
    Peacock, S.
    Clatworthy, M.
    Torpey, N.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2015, 15
  • [8] Clinical features and outcome of relapsed refractory aggressive peripheral T-cell lymphoma - a ten-year study from a single institute in India
    Tilak, T.
    Kumar, L.
    Sharma, A.
    Bakhshi, S.
    Sahoo, R. K.
    Kayal, S.
    Chaudhary, S.
    Raina, V.
    [J]. EUROPEAN JOURNAL OF CANCER, 2013, 49 : S854 - S854
  • [9] Long-term survival with allogeneic stem cell transplant and donor lymphocyte infusion following salvage therapy with Anti-CD52 monoclonal antibody (Campath) in a patient with α/β hepatosplenic T-cell non-Hodgkin's lymphoma
    Chanan-Khan, A
    Islam, T
    Alam, A
    Miller, KC
    Gibbs, J
    Barcos, M
    Czuczman, MS
    Paplham, P
    Hahn, T
    McCarthy, P
    [J]. LEUKEMIA & LYMPHOMA, 2004, 45 (08) : 1673 - 1675